Concepedia

Christopher Fröhlich

CF

12

Publications

366

Citations

10

H-Index

2018

Active since

Affiliations

UiT The Arctic University of Norway(Current)

University Hospital of North Norway

University of Oslo

Université Claude Bernard Lyon 1

Centre National de la Recherche Scientifique

Christopher Fröhlich is an author at UiT The Arctic University of Norway specializing in medicinal chemistry, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

2018–2024

12

Publications

12

OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs

Christopher Fröhlich, Vidar Sørum, Ane Molden Thomassen et al. · mSphere · 2019 · 87 citations · Full text

Evolution of β-lactamase-mediated cefiderocol resistance

Christopher Fröhlich, Vidar Sørum, Nobuhiko Tokuriki et al. · Journal of Antimicrobial Chemotherapy · 2022 · 52 citations · Full text

Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors

Christian Schnaars, Geir Kildahl‐Andersen, Anthony Prandina et al. · ACS Infectious Diseases · 2018 · 44 citations · Full text

Epistasis arises from shifting the rate-limiting step during enzyme evolution of a β-lactamase

Christopher Fröhlich, H. Adrian Bunzel, Karol Buda et al. · Nature Catalysis · 2024 · 44 citations · Full text

ZN148 Is a Modular Synthetic Metallo-β-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens <i>In Vivo</i>

Ørjan Samuelsen, Ove Alexander Høgmoen Åstrand, Christopher Fröhlich et al. · Antimicrobial Agents and Chemotherapy · 2020 · 30 citations · Full text

Rows per page

1–5 of 12